-
GKT137831: Dual Nox1/Nox4 Inhibitor Workflows
2026-09-20
Build reproducible oxidative-stress assays with GKT137831, a dual NADPH oxidase Nox1/Nox4 inhibitor suited to vascular, fibrosis, and metabolic disease models. A membrane-focused ferroptosis study adds a practical lesson: pair reactive oxygen species measurements with late-stage plasma-membrane integrity endpoints rather than relying on one readout.
-
Cefazedone: From MIC Data to Translational Assays
2026-09-19
Cefazedone (Refosporen) is examined through a translational lens, connecting mechanism, MIC methodology, β-lactamase considerations, and pharmacodynamic exposure. This evidence-focused guide shows how to design more interpretable antibacterial testing in vitro rather than simply reproducing comparative rankings.
-
Tumor-Targeted T Cell Engineering in Cold Tumors
2026-09-18
He et al. developed P αCD3&LIGHT, a tumor-targeted plasmid that uses the TERT promoter to co-express LIGHT and membrane-anchored anti-CD3, thereby coordinating T cell recruitment, entry, activation, and persistence in immune-cold tumors. The strategy suppressed several solid tumor models and enhanced checkpoint inhibitor and CAR-T activity, while its translational relevance remains dependent on tumor targeting, delivery, and validation in clinically representative systems.
-
Isoliensinine, TRPV1–AMPK, and MAFLD Fibrosis
2026-09-18
A 2025 Journal of Future Foods study identifies a TRPV1–AMPK mechanism through which isoliensinine from Plumula Nelumbinis restores lipid droplets in hepatic stellate cells and attenuates fibrosis in metabolic associated fatty liver disease models. Its combination of complementary animal models, LX2-cell experiments, and molecular validation provides a mechanistic framework for studying lipid-droplet remodeling in fibrogenesis, while leaving important questions about clinical translation and pathway specificity unresolved.
-
LMO2–LDB1 Signaling in Acute Myeloid Leukemia
2026-09-17
The reference study identifies an LMO2/LDB1 protein complex as a functional driver of acute myeloid leukemia, rather than treating LMO2 only as a prognostic marker. By combining protein-interaction mapping, gene perturbation, transcriptomics, chromatin profiling, and rescue experiments, the work positions LDB1 as an essential co-regulator of leukemic cell proliferation and survival.
-
Energy Stress, AMPK, and Ferroptosis in Proteinopathies
2026-09-17
The reference study shows that energy stress activates an AMPK–ACC1 checkpoint that suppresses ferroptosis across neuronal proteinopathy models. Its combination of cellular, Caenorhabditis elegans, and 3xTg-AD mouse experiments links metabolic sensing to lipid peroxidation, neuronal injury, and disease-relevant behavioral outcomes.
-
HBsAg–TBK1 Crosstalk in Interferon and Autophagy
2026-09-16
The reference study identifies a mechanism by which hepatitis B surface antigen redirects TBK1 signaling away from IRF3-dependent type I interferon production and toward p62-associated autophagy. Its integrated cellular, animal, and patient-tissue analyses suggest that incomplete autophagy may support HBV persistence by weakening antiviral defense and blocking autophagic clearance.
-
Dorsomorphin (Compound C) for AMPK Research
2026-09-16
Dorsomorphin (Compound C) provides reversible control of AMPK while also enabling BMP/Smad pathway studies. This practical guide translates liver-fibrosis findings into cell-based workflows for macrophage polarization, hepatic stellate cell activation, autophagy regulation, and pathway-specific troubleshooting.
-
CLCC1 and Herpesvirus Nuclear Egress Fusion
2026-09-15
A whole-genome CRISPR screen identified the host protein CLCC1 as an essential factor in the membrane-fusion step of herpes simplex virus 1 nuclear egress. The study connects CLCC1 loss to perinuclear capsid accumulation, reduced viral production, and defective nuclear pore complex insertion, suggesting that herpesviruses exploit an ancient cellular membrane-remodeling pathway.
-
HBsAg–TBK1 Control of Interferon and Autophagy
2026-09-15
The 2025 Cell Death and Disease study identifies a mechanism by which hepatitis B surface antigen redirects TBK1 signaling away from IRF3-dependent type I interferon production and toward early, incomplete autophagy. Its combination of molecular interaction studies, TBK1 inhibition, animal models, and human liver tissue analysis links this signaling switch to HBV replication and persistent infection.
-
NADH as a Redox Control in Metabolic Research
2026-09-14
NADH is more than an electron carrier: it is an experimentally actionable variable linking mitochondrial respiration, diabetic nephropathy research, and redox-sensitive disease models. This guide translates NADH/NAD⁺ biology into assay design, handling, and interpretation decisions using evidence from a key diabetic kidney disease review.
-
Hypoxia-Primed hBMSCs Improve Liver Graft IRI
2026-09-14
Luo et al. show that hypoxia-preconditioned human bone marrow-derived mesenchymal stem cells improve mitochondrial quality and transfer more mitochondria to hepatocytes during hepatic ischemia-reperfusion injury. The study identifies connexin 43- and connexin 32-dependent gap-junction communication as an important regulatory interface, while also highlighting the need to distinguish gap-junction facilitation from direct mitochondrial passage through connexin pores.
-
Ivermectin: Causal Assay Design for Parasite Biology
2026-09-13
Ivermectin is a broad-spectrum anti-parasitic compound whose value depends on disciplined exposure, endpoint selection, and mechanistic interpretation. This guide uses insights from GSDMC research to show how parasite assays can distinguish phenotype, target engagement, and translational relevance without overextending oncology findings.
-
EZ Cap™ Firefly Luciferase mRNA for Imaging
2026-09-12
Turn nanoparticle delivery, translation, and cell-response questions into a quantitative luminescence workflow with a Cap1- and poly(A)-optimized reporter. This guide shows how to use EZ Cap™ Firefly Luciferase mRNA for cell assays, formulation comparisons, and longitudinal in vivo bioluminescence imaging while avoiding common interpretation and handling errors.
-
GRE Combination: Anti-Melanogenic Mechanisms
2026-09-11
Huang and colleagues evaluated glabridin, resveratrol, ellagic acid, and their combinations in cellular models of melanogenesis, oxidative stress, and inflammation. Their central finding was that the GRE combination most consistently suppressed melanin production, tyrosinase activity, CREB phosphorylation, MITF-associated responses, DPPH radicals, and LPS-induced nitric oxide production, while the study also highlights important limits of translating in vitro activity into treatment claims.